Mohammad R. Siddiqui

Aug 5, 2024 | bjui-journals.onlinelibrary.wiley.com | Eric V. Li |Sai Kumar |Jonathan Aguiar |Mohammad R. Siddiqui

1 INTRODUCTION Pre-biopsy multiparametric prostate magnetic resonance imaging (mpMRI) increases detection of clinically significant prostate cancer (csPCa, defined as ISUP Grade Group ≥2), while avoiding unnecessary biopsies.1, 2 However, with an estimated 299 010 new cases of prostate cancer in the United States in 2024, there is increasing demand for diagnostic prostate MRI, which requires significant financial resources, availability of scanners, and qualified readers.3, 4 The average cost...

Jun 9, 2024 | nature.com | Eric Li |Mohammad R. Siddiqui |Jonathan Aguiar |Sai Kumar |Edward Schaeffer

AbstractMultiparametric prostate MRI (mpMRI) is being increasingly adopted for work-up of prostate cancer. For patients selected to omit biopsy, we identified factors associated with repeat MRI, eventual prostate biopsy, and subsequent detection of clinically significant prostate cancer (csPCa, Grade Group ≥2).

Mar 27, 2023 | nature.com | Edward Schaeffer |Mohammad R. Siddiqui |Ashorne K. Mahenthiran

Author notesThese authors contributed equally: Mohammad R. Siddiqui, Eric V. Li.Authors and AffiliationsDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USAMohammad R. Siddiqui, Eric V. Li, Sai K. S. R. Kumar, Anna Busza, Jasmine S. Lin, Ashorne K. Mahenthiran, Jonathan A. Aguiar, Parth V. Shah, Brandon Ansbro, Jordan M. Rich, Mary-Kate Keeter, Quan Mai, Edward M. Schaeffer, Hiten D. Patel & Ashley E.